Role of nitric oxide in liver ischemia and reperfusion injury

Molecular and Cellular Biochemistry

Volumn 234-235, Issue , 2002, Pages 229-237

  Hines, Ian N ^a   Kawachi, Shigeyuki ^a   Harada, Hirohisa ^a   Pavlick, Kevin P ^a   Hoffman, Jason M ^a   Bharwani, Sulaiman ^b   Wolf, Robert E ^b   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Cytokines; Inflammation; Interleukin 12; Microcirculation; Mouse; Neutrophils; Reactive oxygen species; TNF ; Transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOKINE; INTERLEUKIN 12; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; ENZYME DEFICIENCY; HISTOPATHOLOGY; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; ANIMAL; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; LIVER; METABOLISM; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; TIME;

ANIMAL; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; LIVER; MICE; MICE, KNOCKOUT; NEUTROPHILS; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; REPERFUSION INJURY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; ANIMALS; NITRIC OXIDE SYNTHASE;

EID: 4243978473     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015952926016     Document Type: Article

References (59)

1. Therapeutic approaches for ischemia/reperfusion injury in the liver
2. Mechanisms of reperfusion injury after warm ischemia of the liver
3. Cytokines and the liver
4. Reperfusion injury after liver preservation for transplantation
5. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver
6. Cell adhesion and migration. III. Leukocyte adhesion and transmigration in the liver vasculature
7. Cellular adhesion molecules: Regulation and functional significance in the pathogenesis of liver diseases
8. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues
9. The potential role of reactive oxygen species in liver ischemia/reperfusion injury following liver surgery
10. Generation of superoxide anion by mitochondria and impairment of their functions during anoxia and reoxygenation in vitro
11. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia
12. Xanthine oxidase and superoxide radicals in portal triad crossclamping-induced microvascular reperfusion injury of the liver
13. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB
14. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappa B activation
15. Regulation of redox glutathione levels and gene transcription in lung inflammation: Therapeutic approaches
16. Regulation of cytokine gene expression: Tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors
17. The taming of IL-12: Suppressing the production of pro-inflammatory cytokines
18. Tumor necrosis factor-alpha and cardiovascular diseases
19. Tumor necrosis factors receptor associated signaling molecules and their role in activation of apoptosis, JNK and NF-kappa B
20. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat
21. Regulation of Fas ligand-induced apoptosis by TNF
22. TNF-induced activation of NF-kappa B
23. Interleukin-12-induced adhesion molecule expression in murine liver
24. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice
25. Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver
26. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia
27. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow
28. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats
29. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R
30. Effects of nitric oxide on iron or hemoprotein-catalyzed oxidative reactions
31. Attenuation of myocardial ischemia/reperfusion injury by super-induction of inducible nitric oxide synthase
32. Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene
33. Nitrosation and oxidation in the regulation of gene expression
34. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver
35. Differential effect of 2-aminoethyl-isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia
36. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
37. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
38. Targeted disruption of the neuronal nitric oxide synthase gene
39. Nitric oxide synthase and postischemic liver injury
40. Enhanced post-ischemic liver injury in iNOS-deficient mice: A cautionary note
41. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC
42. Nitric oxide: An endogenous modulator of leukocyte adhesion
43. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice
44. Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut inflammation
45. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown
46. The role of neutrophils in myocardial ischemia-reperfusion injury
47. Bench to bedside: Tumor necrosis factor alpha: From inflammation to resuscitation
48. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury
49. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B
50. Increased generation of reactive oxygen species in isolated fatty liver during post-ischemic reoxygenation
51. Inhibition of NF-kappa B by S-nitrosylation
52. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives
53. Measurement of nitric oxide and peroxynitrite generation in the post-ischemic heart: Evidence for peroxynitrite-mediated reperfusion injury
54. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide
55. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease
56. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
57. Molecular mechanisms of neutrophil-endothelial cell adhesion induced by redox imbalance
58. Hypoxia-induced upregulation of eNOS gene expression is redox- sensitive: A comparison between hypoxia and inhibitors of cell metabolism
59. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase